You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 12, 2025

Drug Price Trends for VALPROIC ACID


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for VALPROIC ACID

Average Pharmacy Cost for VALPROIC ACID

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
VALPROIC ACID 250 MG CAPSULE 00832-0310-11 0.22996 EACH 2025-01-22
VALPROIC ACID 250 MG CAPSULE 69452-0150-20 0.22996 EACH 2025-01-22
VALPROIC ACID 250 MG/5 ML SOLN 00121-0675-16 0.03471 ML 2025-01-22
VALPROIC ACID 250 MG CAPSULE 63739-0086-10 0.22996 EACH 2025-01-22
VALPROIC ACID 250 MG/5 ML SOLN 70752-0202-12 0.03471 ML 2025-01-22
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for VALPROIC ACID

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
VALPROIC ACID 250MG/5ML SOLN,ORAL Golden State Medical Supply, Inc. 00121-1350-00 100X10ML 45.63 2023-06-23 - 2028-06-14 FSS
VALPROIC ACID 250MG/5ML SOLN,ORAL Golden State Medical Supply, Inc. 00121-4675-40 40X5ML 35.90 2024-04-04 - 2028-06-14 FSS
VALPROIC ACID 250MG/5ML SOLN,ORAL Golden State Medical Supply, Inc. 00121-1350-00 100X10ML 99.46 2024-04-04 - 2028-06-14 FSS
VALPROIC ACID 250MG CAP AvKare, LLC 00591-4012-01 100 14.53 0.14530 EACH 2023-06-15 - 2028-06-14 FSS
VALPROIC ACID 250MG/5ML SOLN,ORAL Golden State Medical Supply, Inc. 00121-4675-00 100X5ML 37.50 2023-06-15 - 2028-06-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for Valproic Acid

Market Overview

Valproic acid, also known as sodium valproate, is a widely used anticonvulsant and mood-stabilizing drug. It is employed in the treatment of epilepsy, bipolar disorder, and other neurological conditions. Here is a comprehensive analysis of the market and price projections for valproic acid.

Market Size and Growth

The global market for valproic acid is anticipated to experience significant growth over the coming years. As of 2023, the global market was valued at approximately $167 million and is forecasted to reach $252.5 million by 2030, growing at a Compound Annual Growth Rate (CAGR) of 5.8% during the period from 2024 to 2030[1].

Key Drivers

Several factors are driving the growth of the valproic acid market:

  • Increasing Prevalence of Epilepsy and Neurological Disorders: The rising global incidence of epilepsy and other seizure disorders is a primary driver. As the population grows and ages, the demand for effective anticonvulsant therapies like valproic acid increases[3].
  • Bipolar Disorder: The growing incidence of bipolar disorder and the need for mood-stabilizing treatments also contribute to market growth. Valproic acid's efficacy in managing manic and depressive episodes makes it a valuable treatment option[3].
  • Generic Formulations: The availability of generic valproic acid formulations has increased market accessibility and affordability, further boosting demand[3].

Market Segmentation

By Type

The valproic acid market is segmented by type into injection, tablet, and liquid formulations. Each type has its own market share and growth prospects:

  • Injection: Used in acute settings or when oral administration is not feasible.
  • Tablet: The most common form, available in various strengths.
  • Liquid: Often used for patients who have difficulty swallowing tablets[1].

By Application

The primary applications of valproic acid include:

  • Epilepsy: Treatment of various types of seizures.
  • Migraines: Prophylactic treatment for migraine headaches.
  • Bipolar Disorder: Management of manic and depressive episodes[1].

By Region

The market exhibits significant regional variations:

  • North America and Europe: These regions are currently dominant due to high prevalence rates of epilepsy and bipolar disorder, along with well-established healthcare systems[3].
  • Asia-Pacific: Expected to witness substantial growth driven by increasing healthcare expenditure and improving access to advanced treatments in countries like China, India, and Japan[3].

Price Analysis

The prices of valproic acid vary based on the formulation and quantity:

Oral Capsule

  • A supply of 60 capsules of 250 mg valproic acid can cost around $22.65 to $23, depending on the pharmacy[2].

Oral Liquid

  • A 473 milliliter supply of 250 mg/5 mL valproic acid oral liquid can cost around $28.40[2].

Intravenous Solution

  • A 50 milliliter supply of 100 mg/mL valproate sodium intravenous solution can cost around $30.51 to $31[5].

Future Outlook

The future of the valproic acid market looks promising, driven by several trends:

  • Advanced Formulations: The development of extended-release, sustained-release, or novel delivery systems such as transdermal patches or intranasal formulations is expected to enhance patient compliance and therapeutic outcomes[3].
  • Market Expansion: Growing healthcare infrastructure and access to neurological treatments in emerging markets will further drive demand[3].

Market Opportunities

  • Novel Formulations: Developing new delivery systems that improve bioavailability and reduce side effects presents a significant opportunity for growth and innovation[3].
  • Combination Products: Integrating valproic acid with other therapies or developing combination products could offer synergistic benefits and enhance treatment efficacy[3].

Competitive Landscape

The valproic acid market is competitive, with several key players:

  • Sanofi
  • AbbVie
  • Athenex
  • Fresenius Kabi
  • Hikma Farmaceutica
  • Desitin Pharmaceuticals
  • Wockhardt
  • Zentiva[1].

Key Takeaways

  • The global valproic acid market is projected to grow from $167 million in 2023 to $252.5 million by 2030.
  • The market is driven by the increasing prevalence of epilepsy and bipolar disorder, as well as the availability of generic formulations.
  • North America and Europe are current market leaders, with the Asia-Pacific region expected to grow significantly.
  • Advanced formulations and market expansion into emerging economies are key future trends.
  • Major players include Sanofi, AbbVie, and Athenex among others.

FAQs

What is the forecasted market size of valproic acid by 2030?

The global market for valproic acid is forecasted to reach $252.5 million by 2030[1].

What are the primary drivers of the valproic acid market?

The primary drivers include the increasing prevalence of epilepsy and other neurological disorders, the rising incidence of bipolar disorder, and the availability of generic formulations[3].

What are the main types of valproic acid formulations?

The main types include injection, tablet, and liquid formulations[1].

Which regions are expected to see significant growth in the valproic acid market?

The Asia-Pacific region, particularly countries like China, India, and Japan, is expected to witness substantial growth[3].

What are some of the key players in the valproic acid market?

Key players include Sanofi, AbbVie, Athenex, Fresenius Kabi, Hikma Farmaceutica, Desitin Pharmaceuticals, Wockhardt, and Zentiva[1].

How much does a typical supply of valproic acid oral capsules cost?

A supply of 60 capsules of 250 mg valproic acid can cost around $22.65 to $23[2].

Sources

  1. Valuates Reports: Sodium Valproate - Market Size.
  2. Drugs.com: Valproic acid Prices, Coupons, Copay Cards & Patient Assistance.
  3. DataHorizon Research: Sodium Valproate Market Size, Share & Forecast 2033.
  4. Prof-Research: Valproic Acid Market Size, Share, Trend and Forecast to 2025.
  5. Drugs.com: Valproate Sodium Prices, Coupons, Copay Cards & Patient Assistance.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.